These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7175374)

  • 41. Relationship of apolipoprotein E phenotypes to hypocholesterolemia.
    Synder SM; Terdiman JF; Caan B; Feingold KR; Hubl ST; Smith RS; Young SG
    Am J Med; 1993 Nov; 95(5):480-8. PubMed ID: 8238064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study.
    Tiret L; de Knijff P; Menzel HJ; Ehnholm C; Nicaud V; Havekes LM
    Arterioscler Thromb; 1994 Oct; 14(10):1617-24. PubMed ID: 7918312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of apolipoprotein E phenotypes in Friedreich's ataxia.
    Bouthillier D; Nestruck AC; Milne R; Sing CF; Barbeau A; Davignon J
    Can J Neurol Sci; 1984 Nov; 11(4 Suppl):626-30. PubMed ID: 6509415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients.
    Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L
    Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.
    Kataoka S; Robbins DC; Cowan LD; Go O; Yeh JL; Devereux RB; Fabsitz RR; Lee ET; Welty TK; Howard BV
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):918-25. PubMed ID: 8696954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.
    Sing CF; Davignon J
    Am J Hum Genet; 1985 Mar; 37(2):268-85. PubMed ID: 3985008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E phenotyping by isoelectric focusing in immobilized pH gradients and silver staining.
    Cartier R; Sassolas A
    Electrophoresis; 1992 Apr; 13(4):252-7. PubMed ID: 1628606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on apoE gene polymorphism in Chinese type II b hyperlipidemia].
    Zhang X; Bai H; Liu B; Fan P; Zhang R; Xu Y; Yao J; Zhu H
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):179-82. PubMed ID: 12600078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease.
    Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker E; Eker D
    Am J Alzheimers Dis Other Demen; 2001; 16(2):77-81. PubMed ID: 11302074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoform patterns of apolipoprotein E in diabetes mellitus.
    Black SC; Hewett S; Kotubi Y; Brunt RV; Reckless JP
    Diabet Med; 1990 Jul; 7(6):532-9. PubMed ID: 2142057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.
    Couderc R; Mahieux F; Bailleul S; Fenelon G; Mary R; Fermanian J
    Stroke; 1993 May; 24(5):661-4. PubMed ID: 8488520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.
    Ehnholm C; Lukka M; Kuusi T; Nikkilä E; Utermann G
    J Lipid Res; 1986 Mar; 27(3):227-35. PubMed ID: 3734624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
    Kesäniemi YA; Ehnholm C; Miettinen TA
    J Clin Invest; 1987 Aug; 80(2):578-81. PubMed ID: 3611358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
    Nemeth A; Szakmary K; Kramer J; Dinya E; Pados G; Fust G; Huettinger M
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):799-804. PubMed ID: 8620056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E polymorphism and atherosclerosis.
    Davignon J; Gregg RE; Sing CF
    Arteriosclerosis; 1988; 8(1):1-21. PubMed ID: 3277611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.
    Wilson PW; Myers RH; Larson MG; Ordovas JM; Wolf PA; Schaefer EJ
    JAMA; 1994 Dec; 272(21):1666-71. PubMed ID: 7966894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1986 Nov; 30(5):422-7. PubMed ID: 3802561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
    Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
    Meigs JB; Ordovas JM; Cupples LA; Singer DE; Nathan DM; Schaefer EJ; Wilson PW
    Diabetes Care; 2000 May; 23(5):669-74. PubMed ID: 10834428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apolipoprotein E polymorphism and hyperlipidemia.
    Assmann G; Schmitz G; Menzel HJ; Schulte H
    Clin Chem; 1984 May; 30(5):641-3. PubMed ID: 6713624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.